Study record · Kisspeptin
Kisspeptin-54 trigger for oocyte maturation in IVF
Kisspeptin induced oocyte maturation across studied doses and pregnancies occurred.
Key result
Kisspeptin induced oocyte maturation across studied doses and pregnancies occurred.
Study details
Study designDose-ranging clinical study
PopulationWomen undergoing IVF
Sample size53
RouteSubcutaneous
Regimen / exposure1.6, 3.2, 6.4 or 12.8 nmol/kg kisspeptin-54
DurationSingle trigger
ComparatorDose groups
Primary endpoint / questionOocyte maturation
Safety resultStudy context involved specialist fertility monitoring.
Key limitationsSpecialist reproductive setting; cannot be extrapolated to unsupervised fertility or libido use.
Registry / identifierPMID 25036713